117 related articles for article (PubMed ID: 8224086)
21. Endothelial cell activation in the presence of African trypanosomes.
Girard M; Giraud S; Courtioux B; Jauberteau-Marchan MO; Bouteille B
Mol Biochem Parasitol; 2005 Jan; 139(1):41-9. PubMed ID: 15610818
[TBL] [Abstract][Full Text] [Related]
22. Identification of a parasitic immunomodulatory protein triggering the development of suppressive M1 macrophages during African trypanosomiasis.
Gómez-Rodríguez J; Stijlemans B; De Muylder G; Korf H; Brys L; Berberof M; Darji A; Pays E; De Baetselier P; Beschin A
J Infect Dis; 2009 Dec; 200(12):1849-60. PubMed ID: 19911988
[TBL] [Abstract][Full Text] [Related]
23. Kinetics of S-adenosylmethionine cellular transport and protein methylation in Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense.
Goldberg B; Rattendi D; Lloyd D; Yarlett N; Bacchi CJ
Arch Biochem Biophys; 1999 Apr; 364(1):13-8. PubMed ID: 10087160
[TBL] [Abstract][Full Text] [Related]
24. Mechanism of resistance of African trypanosomes to cytotoxic human HDL.
Hager KM; Hajduk SL
Nature; 1997 Feb; 385(6619):823-6. PubMed ID: 9039915
[TBL] [Abstract][Full Text] [Related]
25. Effects of human fetal liver extract on the growth of HL-60 cells.
Wu CT; Pei XT; Cong PJ
Exp Hematol; 1989 Mar; 17(3):304-8. PubMed ID: 2917625
[TBL] [Abstract][Full Text] [Related]
26. [Diagnosis of human African trypanosomiasis in 2001].
Louis FJ; Buscher P; Lejon V
Med Trop (Mars); 2001; 61(4-5):340-6. PubMed ID: 11803824
[TBL] [Abstract][Full Text] [Related]
27. Trypanosome-derived oligopeptidase B is released into the plasma of infected rodents, where it persists and retains full catalytic activity.
Morty RE; Lonsdale-Eccles JD; Mentele R; Auerswald EA; Coetzer TH
Infect Immun; 2001 Apr; 69(4):2757-61. PubMed ID: 11254649
[TBL] [Abstract][Full Text] [Related]
28. Anti-Trypanosoma brucei activity of nonprimate zoo sera.
Black SJ; Wang Q; Makadzange T; Li YL; Van Praagh A; Loomis M; Seed JR
J Parasitol; 1999 Feb; 85(1):48-53. PubMed ID: 10207362
[TBL] [Abstract][Full Text] [Related]
29. Experimental therapy of African trypanosomiasis with a nanobody-conjugated human trypanolytic factor.
Baral TN; Magez S; Stijlemans B; Conrath K; Vanhollebeke B; Pays E; Muyldermans S; De Baetselier P
Nat Med; 2006 May; 12(5):580-4. PubMed ID: 16604085
[TBL] [Abstract][Full Text] [Related]
30. [Human resistance to African trypanosoma infections].
Perez-Morga D
Bull Mem Acad R Med Belg; 2007; 162(7-9):381-6; discussion 386. PubMed ID: 18429487
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic and neuropathogenesis issues in human African trypanosomiasis.
Kennedy PG
Int J Parasitol; 2006 May; 36(5):505-12. PubMed ID: 16546191
[TBL] [Abstract][Full Text] [Related]
32. Harbouring in the brain: A focus on immune evasion mechanisms and their deleterious effects in malaria and human African trypanosomiasis.
Bisser S; Ouwe-Missi-Oukem-Boyer ON; Toure FS; Taoufiq Z; Bouteille B; Buguet A; Mazier D
Int J Parasitol; 2006 May; 36(5):529-40. PubMed ID: 16600243
[TBL] [Abstract][Full Text] [Related]
33. O-alkoxyamidine prodrugs of furamidine: in vitro transport and microsomal metabolism as indicators of in vivo efficacy in a mouse model of Trypanosoma brucei rhodesiense infection.
Ansede JH; Anbazhagan M; Brun R; Easterbrook JD; Hall JE; Boykin DW
J Med Chem; 2004 Aug; 47(17):4335-8. PubMed ID: 15294005
[TBL] [Abstract][Full Text] [Related]
34. Novel inhibitors of the trypanosome alternative oxidase inhibit Trypanosoma brucei brucei growth and respiration.
Ott R; Chibale K; Anderson S; Chipeleme A; Chaudhuri M; Guerrah A; Colowick N; Hill GC
Acta Trop; 2006 Dec; 100(3):172-84. PubMed ID: 17126803
[TBL] [Abstract][Full Text] [Related]
35. The pathogenicity of blood stream and central nervous system forms of
Ndungu K; Thuita J; Murilla G; Kagira J; Auma J; Mireji P; Ngae G; Okumu P; Gitonga P; Guya S; Mdachi R
F1000Res; 2022; 11():260. PubMed ID: 38162635
[No Abstract] [Full Text] [Related]
36. Endosomal localization of the serum resistance-associated protein in African trypanosomes confers human infectivity.
Stephens NA; Hajduk SL
Eukaryot Cell; 2011 Aug; 10(8):1023-33. PubMed ID: 21705681
[TBL] [Abstract][Full Text] [Related]
37. Cutaneous manifestations of African trypanosomiasis.
McGovern TW; Williams W; Fitzpatrick JE; Cetron MS; Hepburn BC; Gentry RH
Arch Dermatol; 1995 Oct; 131(10):1178-82. PubMed ID: 7574836
[TBL] [Abstract][Full Text] [Related]
38. Studies on the mechanisms supporting the continuous growth of Trypanosoma (Trypanozoon) brucei as bloodstream-like form in vitro.
Tanner M
Acta Trop; 1980 Sep; 37(3):203-20. PubMed ID: 6106356
[TBL] [Abstract][Full Text] [Related]
39. Transcriptomes of Trypanosoma brucei rhodesiense from sleeping sickness patients, rodents and culture: Effects of strain, growth conditions and RNA preparation methods.
Mulindwa J; Leiss K; Ibberson D; Kamanyi Marucha K; Helbig C; Melo do Nascimento L; Silvester E; Matthews K; Matovu E; Enyaru J; Clayton C
PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006280. PubMed ID: 29474390
[TBL] [Abstract][Full Text] [Related]
40. The structure of serum resistance-associated protein and its implications for human African trypanosomiasis.
Zoll S; Lane-Serff H; Mehmood S; Schneider J; Robinson CV; Carrington M; Higgins MK
Nat Microbiol; 2018 Mar; 3(3):295-301. PubMed ID: 29358741
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
